EKF Diagnostics has entered a multi-year, collaborative relationship with Joslin Diabetes Center in support of the ongoing clinical and commercial translation of TNFR1 & 2 biomarkers.
EKF Diagnostics will be exhibiting at ASN 2014 in Philadelphia on 11th -16th November.
EKF Diagnostics, announces that it will be introducing a new diagnostic test at Medica 2014, 12-15th November, Düsseldorf, Germany.
EKF Diagnostics will be exhibiting Biosen and Quo-Test on stand HN5 – J34 at this year’s CMEF Exhibition.
EKF held its first International Distributor Meeting in Rome from Monday 22nd-24th September.
EKF Diagnostics announces that it has entered into a two year research collaboration with Massachusetts General Hospital to develop PointMan assays that detect treatable cancer mutations in blood.
For the second time this year the company EKF-diagnostic GmbH called to donate blood for a good cause.
On September 10th 2014, 19 companies met at a start-up event for a new medical and sanitary engineering group in Saxony-Anhalt.
Improved detection of Oxidative DNA Damage and Genotoxicity.
From early detection of ketosis to cancer mutation testing in whole blood.
Copyright © 2019 | Powered by Intergage